Aandeel ACBM ACRO BIOMEDICAL CO., LTD.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen Acro Biomedical Co., Ltd. Other OTC

Aandelen

ACBM

US0048921052

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
ACRO BIOMEDICAL CO., LTD. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
Acro Biomedical Co., Ltd. Auditor Raises 'Going Concern' Doubt
ACRO BIOMEDICAL CO., LTD. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Acro Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021
ACRO BIOMEDICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
Acro Biomedical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers ACBM
  4. Koers ACBM
  5. Nieuws Acro Biomedical Co., Ltd.
  6. Andere talen